UNSPSC 51102869: Oxytetracycline/phenazopyridine/sulfamethizole

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class AM900. This VA Drug Class (AM900) classifies this compound as belonging to the group ANTI-INFECTIVES, OTHER.

UNSPSC 51102869 Oxytetracycline/phenazopyridine/sulfamethizole is a Commodity code that shows limited recent activity aligned with its stated scope. The recent state and local opportunities tagged under this code primarily solicit naloxone and drug deactivation systems, medical and first aid supplies for emergency response, generic pharmaceuticals through cooperative purchasing, and direct-to-manufacturer prescription programs—a mix that diverges significantly from the specific antibiotic-sulfonamide combination the code nominally describes. State and local governments are using this code to procure a broader range of pharmaceuticals, medical supplies, and pharmacy program infrastructure rather than the narrow drug formulation the code name suggests. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP).

Recent opportunities span Florida, Texas, and Minnesota, with MMCAP's cooperative vehicle extending to Oregon. The Seminole County IFB (IFB60459723LAS), posted June 30, 2026, seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries, due July 26, 2023. The City of Tampa's ITB (26P00145), posted March 25, 2026, solicits 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a March 13, 2026 deadline, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance issued an RFP (S1070000015802) for generic multi-source pharmaceuticals and OTC products due March 26, 2026, with awards effective July 1, 2026 and contract terms of two years. The Texas HHS Commission's RFI (HHS0017013), posted April 3, 2026, explores vendor capacity for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager channels. The code's actual procurement activity shows substantial state and local volume in emergency medical supplies and pharmaceutical cooperative contracting, but the nominal code definition does not align cleanly with what is being purchased.